You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CUPRIC CHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cupric Chloride, and what generic alternatives are available?

Cupric Chloride is a drug marketed by Exela Pharma, Rk Pharma, Somerset, and Hospira. and is included in four NDAs.

The generic ingredient in CUPRIC CHLORIDE is cupric chloride. Five suppliers are listed for this compound. Additional details are available on the cupric chloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cupric Chloride

A generic version of CUPRIC CHLORIDE was approved as cupric chloride by EXELA PHARMA on October 31st, 2022.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CUPRIC CHLORIDE?
  • What are the global sales for CUPRIC CHLORIDE?
  • What is Average Wholesale Price for CUPRIC CHLORIDE?
Summary for CUPRIC CHLORIDE
Drug patent expirations by year for CUPRIC CHLORIDE

US Patents and Regulatory Information for CUPRIC CHLORIDE

CUPRIC CHLORIDE is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting CUPRIC CHLORIDE

COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma CUPRIC CHLORIDE cupric chloride INJECTABLE;INJECTION 212071-001 Oct 31, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira CUPRIC CHLORIDE IN PLASTIC CONTAINER cupric chloride INJECTABLE;INJECTION 018960-001 Jun 26, 1986 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rk Pharma CUPRIC CHLORIDE cupric chloride INJECTABLE;INJECTION 217626-001 Apr 30, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Somerset CUPRIC CHLORIDE cupric chloride INJECTABLE;INJECTION 216113-001 Apr 30, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.